Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Demaria

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Oncotarget|April 27, 2012
Pro-malignant properties of STAT3 during chronic inflammationMarco Demaria, Valeria Poli
JAK-STAT|September 24, 2013
PKM2, STAT3 and HIF-1α: The Warburg's vicious circleMarco Demaria, Valeria Poli
Aging|May 19, 2026
Public health in the age of longevity interventions: from prevention to system-wide resilienceJochen Mierau, Marco Demaria
Drug Discovery Today|January 24, 2017
Therapeutic interventions for aging: the case of cellular senescenceAbel Soto-Gamez, Marco Demaria
Current Biology : CB|May 24, 2022
Cellular senescenceMarta Varela-Eirín, Marco Demaria
Trends in Cancer|September 22, 2021
A novel transcriptomic-based classifier for senescent cancer cellsFeba Mariam Varughese, Marco Demaria
Gerontology|April 1, 2016
Targeting Senescent Cells: Possible Implications for Delaying Skin Aging: A Mini-ReviewMichael C Velarde, Marco Demaria
International Journal of Cancer|February 7, 2014
STAT3 and metabolism: how many ways to use a single molecule?Marco Demaria, Annalisa Camporeale, Valeria Poli
Oncotarget|February 28, 2018
A novel suicide gene therapy for the treatment of p16<sup>Ink4a</sup>-overexpressing tumorsJaskaren Kohli, Judith Campisi, Marco Demaria
EMBO Reports|May 28, 2026
Response to: Limitations of the p16-3MR mouse model for detecting and eliminating senescent cellsBoshi Wang, Jamil Nehme, Marco Demaria
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Oncotarget|April 27, 2012
Pro-malignant properties of STAT3 during chronic inflammationMarco Demaria, Valeria Poli
JAK-STAT|September 24, 2013
PKM2, STAT3 and HIF-1α: The Warburg's vicious circleMarco Demaria, Valeria Poli
Aging|May 19, 2026
Public health in the age of longevity interventions: from prevention to system-wide resilienceJochen Mierau, Marco Demaria
Drug Discovery Today|January 24, 2017
Therapeutic interventions for aging: the case of cellular senescenceAbel Soto-Gamez, Marco Demaria
Current Biology : CB|May 24, 2022
Cellular senescenceMarta Varela-Eirín, Marco Demaria
Trends in Cancer|September 22, 2021
A novel transcriptomic-based classifier for senescent cancer cellsFeba Mariam Varughese, Marco Demaria
Gerontology|April 1, 2016
Targeting Senescent Cells: Possible Implications for Delaying Skin Aging: A Mini-ReviewMichael C Velarde, Marco Demaria
International Journal of Cancer|February 7, 2014
STAT3 and metabolism: how many ways to use a single molecule?Marco Demaria, Annalisa Camporeale, Valeria Poli
Oncotarget|February 28, 2018
A novel suicide gene therapy for the treatment of p16<sup>Ink4a</sup>-overexpressing tumorsJaskaren Kohli, Judith Campisi, Marco Demaria
EMBO Reports|May 28, 2026
Response to: Limitations of the p16-3MR mouse model for detecting and eliminating senescent cellsBoshi Wang, Jamil Nehme, Marco Demaria
Pageof 11